Newsroom
Latest News
News
SERA REPORTS FOURTH QUARTER 2022 FINANCIAL RESULTS
SALT LAKE CITY, March 22, 2023 — Sera Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients,…
News
Sera Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2022 Financial Results on March 22, 2023
Sera, Inc., announced that it will report fourth quarter and full year 2022 financial results on Wednesday, March 22, 2023, after the close of the market.
News
SERA TO PRESENT AT UPCOMING MARCH INVESTOR CONFERENCES
Sera Inc. announced that the company will present at the upcoming Cowen Health Care Conference March 6-8, 2023 in Boston and the Oppenheimer 33rd Annual Healthcare Conference held to be held virtually March 13-15, 2023.
News
Sera Announces Positive Top-line Data from AVERT PRETERM TRIAL
PreTRM® test-and-treat strategy demonstrates statistically and clinically significant improvement in neonatal health outcomes and hospital length-of-stay
News
FORS MARSH TO INCLUDE THE PreTRM® TEST IN ITS EMPLOYEE MATERNITY BENEFITS PACKAGE IN COLLABORATION WITH SERA
Sera and Fors Marsh are collaborating to provide Sera’s PreTRM® Test to employees at Fors Marsh as part of their maternity benefits, effective January 1, 2023.
News
SERA ANNOUNCES PUBLICATION OF DATA PREDICTING CLINICAL UTILITY AND COST EFFECTIVENESS OF THE PRETRM® TEST-AND-TREAT STRATEGY ACROSS DIVERSE POPULATIONS
Sera Inc. announced the publication of results from a clinical utility and cost-effectiveness modeling study, ACCORDANT (Analyses aCross Congruent studies ReDucing Adverse pregNancy ouTcomes).
News
SERA REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
SALT LAKE CITY, Nov. 9, 2022 /PRNewswire/ — Sera Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced…
News
Sera Announces Conference Call and Webcast of Third Quarter Fiscal Year 2022 Financial Results on November 9
Sera announced that it will report third quarter fiscal year 2022 financial results on Wednesday, November 9, 2022, after the close of the market.
News
SONRAVA HEALTH TO INCLUDE THE PreTRM® TEST IN ITS EMPLOYEE MATERNITY BENEFITS PACKAGE IN COLLABORATION WITH CEREBRAE AND SERA
Sera Inc., focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, Sonrava Health, a national family of health and wellness companies, and Cerebrae, an innovator in pricing and measuring the financial value of care, are collaborating to provide Sera’s PreTRM® Test to members of Sonrava Health’s employer-sponsored health insurance program.
News
BANNER HEALTH, SERA TEAM UP TO PROVIDE PreTRM® TEST TO COVERED PREGNANT MEMBERS
Sera Inc., The Pregnancy Company® (NASDAQ: SERA), and Banner Health today announced that Sera’s PreTRM® Test will be available to Banner – University Family Care/ AHCCCS Complete Care (B – UFC/ACC) members.